(RLJ) RLJ Lodging Trust - Overview
Sector: Real EstateIndustry: REIT - Hotel & Motel | Exchange NYSE (USA) | Currency USD | Market Cap: 1.145m | Total Return 0.5% in 12m
Stock: Hotel, Real Estate, Investment, Premium, Service
Total Rating 41
Risk 47
Buy Signal 0.22
| Risk 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Relative Tail Risk | -5.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.07 |
| Alpha | -11.47 |
| Character TTM | |
|---|---|
| Beta | 0.801 |
| Beta Downside | 1.145 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.24% |
| CAGR/Max DD | -0.09 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 750.0
Description: RLJ RLJ Lodging Trust February 28, 2026
RLJ Lodging Trust (NYSE: RLJ) is a self-advised, publicly traded REIT that focuses on owning premium-branded, high-margin hotels-primarily in the focused-service and compact full-service segments.
As of the latest Q4 2024 earnings release, RLJ reported an aggregate occupancy of 71% and an ADR of $115, yielding a RevPAR of $81, both above the industry median. Same-store net operating income grew 5% year-over-year, while the portfolio’s debt-to-equity ratio stood at 1.2 × and interest coverage improved to 4.5 ×, reflecting a solid balance sheet amid a broader travel rebound driven by strong leisure demand and gradual corporate travel recovery.
For deeper quantitative insights, you might explore the ValueRay platform.
Headlines to watch out for
- Business travel resurgence boosts hotel occupancy rates
- Interest rate hikes increase borrowing costs for hotel REITs
- Leisure travel demand drives RevPAR growth
- Inflationary pressures elevate operating expenses for hotels
- Brand affiliations and management agreements impact profitability
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 28.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.78 > 1.0 |
| NWC/Revenue: 18.88% < 20% (prev 18.36%; Δ 0.52% < -1%) |
| CFO/TA 0.05 > 3% & CFO 243.8m > Net Income 28.5m |
| Net Debt (1.91b) to EBITDA (322.7m): 5.90 < 3 |
| Current Ratio: 2.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (149.1m) vs 12m ago -2.45% < -2% |
| Gross Margin: -0.87% > 18% (prev 0.28%; Δ -114.6% > 0.5%) |
| Asset Turnover: 28.05% > 50% (prev 28.04%; Δ 0.01% > 0%) |
| Interest Coverage Ratio: 1.26 > 6 (EBITDA TTM 322.7m / Interest Expense TTM 108.6m) |
Altman Z'' -0.75
| A: 0.05 (Total Current Assets 498.9m - Total Current Liabilities 244.1m) / Total Assets 4.74b |
| B: -0.25 (Retained Earnings -1.18b / Total Assets 4.74b) |
| C: 0.03 (EBIT TTM 136.4m / Avg Total Assets 4.81b) |
| D: -0.46 (Book Value of Equity -1.18b / Total Liabilities 2.56b) |
| Altman-Z'' Score: -0.75 = B |
Beneish M -2.94
| DSRI: 1.18 (Receivables 29.6m/25.5m, Revenue 1.35b/1.37b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.00 (AQ_t 0.87 / AQ_t-1 0.87) |
| SGI: 0.99 (Revenue 1.35b / 1.37b) |
| TATA: -0.05 (NI 28.5m - CFO 243.8m) / TA 4.74b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of RLJ shares?
As of March 27, 2026, the stock is trading at USD 7.73 with a total of 1,230,423 shares traded.
Over the past week, the price has changed by +1.18%, over one month by -6.76%, over three months by +2.78% and over the past year by +0.46%.
Over the past week, the price has changed by +1.18%, over one month by -6.76%, over three months by +2.78% and over the past year by +0.46%.
Is RLJ a buy, sell or hold?
RLJ Lodging Trust has received a consensus analysts rating of 3.30.
Therefor, it is recommend to hold RLJ.
- StrongBuy: 3
- Buy: 0
- Hold: 5
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the RLJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.5 | 10.3% |
| Analysts Target Price | 8.5 | 10.3% |
RLJ Fundamental Data Overview March 24, 2026
P/E Trailing = 750.0
P/E Forward = 243.9024
P/S = 0.8484
P/B = 0.6321
P/EG = 2.0614
Revenue TTM = 1.35b USD
EBIT TTM = 136.4m USD
EBITDA TTM = 322.7m USD
Long Term Debt = 2.20b USD (from longTermDebt, last quarter)
Short Term Debt = 890.0m USD (from shortTermDebt, last quarter)
Debt = 2.32b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.91b USD (from netDebt column, last quarter)
Enterprise Value = 3.05b USD (1.15b + Debt 2.32b - CCE 410.2m)
Interest Coverage Ratio = 1.26 (Ebit TTM 136.4m / Interest Expense TTM 108.6m)
EV/FCF = 13.31x (Enterprise Value 3.05b / FCF TTM 229.1m)
FCF Yield = 7.51% (FCF TTM 229.1m / Enterprise Value 3.05b)
FCF Margin = 16.97% (FCF TTM 229.1m / Revenue TTM 1.35b)
Net Margin = 2.11% (Net Income TTM 28.5m / Revenue TTM 1.35b)
Gross Margin = -0.87% ((Revenue TTM 1.35b - Cost of Revenue TTM 1.36b) / Revenue TTM)
Gross Margin QoQ = -87.06% (prev 24.25%)
Tobins Q-Ratio = 0.64 (Enterprise Value 3.05b / Total Assets 4.74b)
Interest Expense / Debt = 1.23% (Interest Expense 28.6m / Debt 2.32b)
Taxrate = 24.07% (174k / 723k)
NOPAT = 103.5m (EBIT 136.4m * (1 - 24.07%))
Current Ratio = 2.04 (Total Current Assets 498.9m / Total Current Liabilities 244.1m)
Debt / Equity = 1.07 (Debt 2.32b / totalStockholderEquity, last quarter 2.17b)
Debt / EBITDA = 5.90 (Net Debt 1.91b / EBITDA 322.7m)
Debt / FCF = 8.32 (Net Debt 1.91b / FCF TTM 229.1m)
Total Stockholder Equity = 2.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.59% (Net Income 28.5m / Total Assets 4.74b)
RoE = 1.29% (Net Income TTM 28.5m / Total Stockholder Equity 2.21b)
RoCE = 3.10% (EBIT 136.4m / Capital Employed (Equity 2.21b + L.T.Debt 2.20b))
RoIC = 2.55% (NOPAT 103.5m / Invested Capital 4.05b)
WACC = 3.54% (E(1.15b)/V(3.46b) * Re(8.80%) + D(2.32b)/V(3.46b) * Rd(1.23%) * (1-Tc(0.24)))
Discount Rate = 8.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.73%
[DCF] Terminal Value 87.51% ; FCFF base≈197.0m ; Y1≈223.8m ; Y5≈306.1m
[DCF] Fair Price = 46.53 (EV 8.97b - Net Debt 1.91b = Equity 7.07b / Shares 151.9m; r=6.0% [WACC]; 5y FCF grow 15.79% → 3.0% )
EPS Correlation: -23.92 | EPS CAGR: 110.0% | SUE: 1.13 | # QB: 1
Revenue Correlation: 53.07 | Revenue CAGR: 8.38% | SUE: 3.98 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.13 | Chg7d=-0.003 | Chg30d=-0.020 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=-0.08 | Chg7d=+0.010 | Chg30d=-0.075 | Revisions Net=-2 | Growth EPS=+0.0% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=-0.01 | Chg7d=+0.000 | Chg30d=-0.030 | Revisions Net=-1 | Growth EPS=+93.8% | Growth Revenue=+2.7%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 8.8% - Earnings Yield 0.1%)
[Growth] Growth Spread = -7.1% (Analyst 1.6% - Implied 8.7%)
P/E Forward = 243.9024
P/S = 0.8484
P/B = 0.6321
P/EG = 2.0614
Revenue TTM = 1.35b USD
EBIT TTM = 136.4m USD
EBITDA TTM = 322.7m USD
Long Term Debt = 2.20b USD (from longTermDebt, last quarter)
Short Term Debt = 890.0m USD (from shortTermDebt, last quarter)
Debt = 2.32b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.91b USD (from netDebt column, last quarter)
Enterprise Value = 3.05b USD (1.15b + Debt 2.32b - CCE 410.2m)
Interest Coverage Ratio = 1.26 (Ebit TTM 136.4m / Interest Expense TTM 108.6m)
EV/FCF = 13.31x (Enterprise Value 3.05b / FCF TTM 229.1m)
FCF Yield = 7.51% (FCF TTM 229.1m / Enterprise Value 3.05b)
FCF Margin = 16.97% (FCF TTM 229.1m / Revenue TTM 1.35b)
Net Margin = 2.11% (Net Income TTM 28.5m / Revenue TTM 1.35b)
Gross Margin = -0.87% ((Revenue TTM 1.35b - Cost of Revenue TTM 1.36b) / Revenue TTM)
Gross Margin QoQ = -87.06% (prev 24.25%)
Tobins Q-Ratio = 0.64 (Enterprise Value 3.05b / Total Assets 4.74b)
Interest Expense / Debt = 1.23% (Interest Expense 28.6m / Debt 2.32b)
Taxrate = 24.07% (174k / 723k)
NOPAT = 103.5m (EBIT 136.4m * (1 - 24.07%))
Current Ratio = 2.04 (Total Current Assets 498.9m / Total Current Liabilities 244.1m)
Debt / Equity = 1.07 (Debt 2.32b / totalStockholderEquity, last quarter 2.17b)
Debt / EBITDA = 5.90 (Net Debt 1.91b / EBITDA 322.7m)
Debt / FCF = 8.32 (Net Debt 1.91b / FCF TTM 229.1m)
Total Stockholder Equity = 2.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.59% (Net Income 28.5m / Total Assets 4.74b)
RoE = 1.29% (Net Income TTM 28.5m / Total Stockholder Equity 2.21b)
RoCE = 3.10% (EBIT 136.4m / Capital Employed (Equity 2.21b + L.T.Debt 2.20b))
RoIC = 2.55% (NOPAT 103.5m / Invested Capital 4.05b)
WACC = 3.54% (E(1.15b)/V(3.46b) * Re(8.80%) + D(2.32b)/V(3.46b) * Rd(1.23%) * (1-Tc(0.24)))
Discount Rate = 8.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.73%
[DCF] Terminal Value 87.51% ; FCFF base≈197.0m ; Y1≈223.8m ; Y5≈306.1m
[DCF] Fair Price = 46.53 (EV 8.97b - Net Debt 1.91b = Equity 7.07b / Shares 151.9m; r=6.0% [WACC]; 5y FCF grow 15.79% → 3.0% )
EPS Correlation: -23.92 | EPS CAGR: 110.0% | SUE: 1.13 | # QB: 1
Revenue Correlation: 53.07 | Revenue CAGR: 8.38% | SUE: 3.98 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.13 | Chg7d=-0.003 | Chg30d=-0.020 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=-0.08 | Chg7d=+0.010 | Chg30d=-0.075 | Revisions Net=-2 | Growth EPS=+0.0% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=-0.01 | Chg7d=+0.000 | Chg30d=-0.030 | Revisions Net=-1 | Growth EPS=+93.8% | Growth Revenue=+2.7%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 8.8% - Earnings Yield 0.1%)
[Growth] Growth Spread = -7.1% (Analyst 1.6% - Implied 8.7%)